InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Lalwani Nikhil, Chairman & CEO. Officer active across 1 company, notably ANI Pharmaceuticals INC. In total, 6 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €181k. Activity tracked since 8 September 2021. The latest transaction was disclosed on 27 April 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
33,352 shares0Common StockSEC:0001415889-22-004403:0
100,055 shares0Common StockSEC:0001415889-22-003392:0
17,454 shares@ US$27.030.024% mcap58.4% of flowCommon StockSEC:0001415889-22-003380:0
7,224 shares@ US$27.68510.010% mcap24.7% of flowCommon StockSEC:0001415889-22-003308:0
Ideal exit: 16 Dec 2022 (T+270)
2,577 shares@ US$28.200.0035% mcap100.0% of flowCommon StockSEC:0001415889-21-004348
2,577 shares@ US$28.200.0035% mcap8.4% of flowCommon StockSEC:0001415889-21-004348:0
6 of 6 declarations
About Lalwani Nikhil
Nikhil Lalwani is the President and Chief Executive Officer of ANI PHARMACEUTICALS INC. He leads the company with a strategic vision, focusing on innovation and the expansion of pharmaceutical products. With a strong background in the industry, he is committed to improving the company's outcomes while addressing the needs of patients and healthcare professionals.
